Home » Alere Reports 2 Percent Dip in Q2 Revenues Despite Lift in Infectious Disease Sales

Alere Reports 2 Percent Dip in Q2 Revenues Despite Lift in Infectious Disease Sales

Sep 06, 2016
|
staff reporter

NEW YORK (GenomeWeb) – Alere today filed its financial results for the second quarter of 2016, reporting a 2 percent decrease in revenues year over year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Scan

Try the Other Version

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

You Do Your Way

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

CRISPR Discussions

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

This Week in Science

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.

What's Popular?

In Molecular Diagnostics

  1. ASCO Updates NSCLC Guidelines With New Directives for Genomic Testing

  2. Myriad Genetics' Breast Cancer Recurrence Test Wins Positive Coverage From Palmetto, Anthem

  3. Color Raises $52M of Planned $80M Financing

  4. Biocept, UT Southwestern Partner for ALK Liquid Biopsy Study

  5. Dutch Researchers Develop ThromboSeq Test to Detect Lung Cancer

Sponsorships

Privacy Policy.  Copyright © 2017 GenomeWeb LLC.  All Rights Reserved.